ARTICLE | Clinical News
Sativex sublingual cannabis extract spray: Updated Phase III data
November 19, 2007 8:00 AM UTC
Researchers published in Pain previously reported data from a double-blind, placebo-controlled Phase III trial in 125 patients with neuropathic pain who failed previous analgesic therapy showing that ...